Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine versus metoclopramide for gastric residual volume in mechanically ventilated ICU patients
IRCT201412044365N18Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of neostigmine and metoclopramide in feeding intolerance (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Gastric residual volume. Started Feb 2013; status: completed.
02
Drugs
neostigminemetoclopramide
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on IRCT201412044365N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201412044365N18.